X-Biotix Therapeutics, Inc. — Form D/A
X-Biotix Therapeutics, Inc. of Waltham, MA, a company, filed a Form D amendment with the SEC on 2019-06-25. The offering totals $9.4M, of which $9.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-06-25
- Form: D/A
- Accession: 0001567619-19-013963
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $9.4M
- Amount sold: $9.4M
- Investors: 7
- Date of first sale: 2018-04-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-311133
Issuer
- Name: X-Biotix Therapeutics, Inc.
- CIK: 0001738806
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 465 Waverly Oaks Rd., Ste. 414, Waltham, MA, 02452
- Phone: 781.419.6945
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Stephen T Isaacs | Director | Waltham, MA |
| Christopher D Ray | Director | Waltham, MA |
| Ramani Varanasi | Director | Waltham, MA |
| Ramani Varanasi | Executive Officer | Waltham, MA |
| David D Cook, Ph.D. | Director | Waltham, MA |
| Dominic D Ryan | Executive Officer | Waltham, MA |
| Thomas G Bernhardt Ph.D. | Executive Officer | WALTHAM, MA |
| M. Dominic Ryan Ph.D. | Executive Officer | WALTHAM, MA |
Other filings by this issuer (3)
More